InvestSMART

IperionX Limited (ASX: IPX) - Announcements

Current share price for IPX : $3.600 0.16 (4.65%)+

ASX company news and announcements for IperionX Limited (IPX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All IperionX Limited (IPX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than IperionX Limited (IPX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for IperionX Limited (IPX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$1,304 Notice under Section 708A 24 Feb 2026 9:44AM $5.850 $3.600 fallen by 38.46%
$1,304 Application for quotation of securities - IPX 24 Feb 2026 9:43AM $5.850 $3.600 fallen by 38.46%
$1,304 Application for quotation of securities - IPX 24 Feb 2026 9:37AM $5.850 $3.600 fallen by 38.46%
$1,304 Prospectus Supplement to Shelf Registration (Form F-3) 24 Feb 2026 9:34AM $5.850 $3.600 fallen by 38.46%
$1,304 Change in substantial holding 19 Feb 2026 8:09AM $5.830 $3.600 fallen by 38.25%
$1,304 Notice of General Meeting/Proxy Form 13 Feb 2026 6:33PM $5.550 $3.600 fallen by 35.14%
$1,304 Change of Director's Interest Notice 9 Feb 2026 5:30PM $6.160 $3.600 fallen by 41.56%
$1,304 Appointment of Company Secretary 9 Feb 2026 9:47AM $5.780 $3.600 fallen by 37.72%
$1,304 Change of Director's Interest Notice x2 3 Feb 2026 4:50PM $6.790 $3.600 fallen by 46.98%
$1,304 Notice under Section 708A 3 Feb 2026 4:40PM $6.790 $3.600 fallen by 46.98%
$1,304 Application for quotation of securities - IPX 3 Feb 2026 4:40PM $6.790 $3.600 fallen by 46.98%
$1,304 Letter to Shareholders 2 Feb 2026 9:15AM $7.350 $3.600 fallen by 51.02%
$1,304 December 2025 Quarterly Report 30 Jan 2026 9:46AM $7.670 $3.600 fallen by 53.06%
$1,304 Change in substantial holding 30 Jan 2026 8:57AM $7.670 $3.600 fallen by 53.06%
$1,304 Change in substantial holding 23 Jan 2026 9:27AM $7.790 $3.600 fallen by 53.79%
$1,304 IperionX Receives Order for U.S. Army Ground Combat Systems 22 Jan 2026 9:31AM $7.390 $3.600 fallen by 51.29%
$1,304 Becoming a substantial holder 22 Jan 2026 8:47AM $7.390 $3.600 fallen by 51.29%
$1,304 IperionX receives $4.6m funding and 290t scrap from US Govt. 16 Jan 2026 9:22AM $6.990 $3.600 fallen by 48.50%
$1,304 Notification of cessation of securities - IPX 9 Jan 2026 5:18PM $6.370 $3.600 fallen by 43.49%
$1,304 Expiry of Vendor Performance Securities 23 Dec 2025 6:05PM $5.170 $3.600 fallen by 30.37%
$1,304 Change of Director's Interest Notice x7 23 Dec 2025 6:03PM $5.170 $3.600 fallen by 30.37%
$1,304 Notice under Section 708A 23 Dec 2025 5:59PM $5.170 $3.600 fallen by 30.37%
$1,304 Application for quotation of securities - IPX 23 Dec 2025 5:56PM $5.170 $3.600 fallen by 30.37%
$1,304 Notification of cessation of securities - IPX 23 Dec 2025 5:49PM $5.170 $3.600 fallen by 30.37%
$1,304 Notification regarding unquoted securities - IPX 23 Dec 2025 5:49PM $5.170 $3.600 fallen by 30.37%

51 - 75 of 464 results

Page 3 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.